WEARABLE TECHNOLOGIES IN CLINICAL TRIALS FOR DRUG DEVELOPMENT: TRENDS AND EMERGING OPPORTUNITIES

Abstract

Wearable technologies have emerged as transformative tools in modern clinical trials and pharmaceutical drug development by enabling continuous physiological monitoring, remote patient assessment, real-time data collection, and decentralized clinical research. Conventional clinical trial methodologies frequently encounter challenges including limited patient engagement, poor adherence, geographic restrictions, delayed data acquisition, and high operational costs. The integration of wearable devices into clinical research environments has significantly improved patient monitoring capabilities, data accuracy, therapeutic assessment, and healthcare accessibility.Wearable technologies include smartwatches, biosensors, fitness trackers, electrocardiographic monitors, glucose monitoring systems, wearable patches, and implantable monitoring devices capable of measuring physiological parameters such as heart rate, sleep quality, physical activity, blood glucose, oxygen saturation, temperature, and neurological responses. These technologies support remote monitoring and real-world evidence generation during drug development processes.Artificial intelligence, cloud computing, machine learning, wireless communication systems, and mobile health applications further enhance the analytical capabilities of wearable technologies by enabling predictive analytics, automated alerts, and personalized healthcare insights. Pharmaceutical companies increasingly utilize wearable systems in decentralized clinical trials to improve participant retention, treatment adherence, and real-time safety surveillance.Pharmacists contribute significantly to wearable-assisted clinical research through medication therapy management, patient counseling, adherence monitoring, pharmacovigilance, and data interpretation. Collaborative integration between pharmacists, clinicians, biomedical engineers, and data scientists supports optimized therapeutic outcomes and evidence-based clinical decision-making.Despite substantial benefits, important challenges remain regarding regulatory compliance, cybersecurity, patient privacy, device accuracy, data standardization, interoperability, and ethical considerations. This manuscript explores the evolution, technologies, applications, pharmacist interventions, benefits, limitations, ethical concerns, statistical trends, and future opportunities of wearable technologies in clinical trials and pharmaceutical drug development.